This report, from Stratview Research, studies The Global Breast Cancer Liquid Biopsy Market over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
The Burning Questions This Report Will Answer:
Oncologists believe that monitoring and therapy selection of metastatic breast cancers shall be the major focus for the next few years and hence attractive. However, from the point of view of a market stakeholder this segment is highly crowded and competitive. So how does each stakeholder make money and sustain their market share?
According to JP Morgan analysis, this segment could be worth $2bn a year by 2020. In the next 2-3 years, liquid biopsy technology will also come to be used for predicting the likely course and outcome of disease for individual patients. Improved patient experience from a non-invasive approach to molecular profiling of a tumor compared with tissue biopsy, especially for patients who require serial biopsies are the few factors that are likely to drive this market in the US, Europe and APAC.
One of the key challenges to uptake of liquid biopsy is the cost of actual sequencing: at present, it is only possible to obtain an adequate depth of sequencing at a cost that is too expensive for routine clinical use. The report looks at the positive side of this market as well as the possible hurdles which can make the stakeholders re-strategize their plans again and again in the developed and developing markets.
The report also looks at the opportunity geography wise hence giving a 360 degree view of the market, its opportunities and gaps for the reader.
Our reports offer high-quality insights and are the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. About 10 detailed primary interviews with the market players across the value chain in all four regions and industry experts have been executed to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
The Global Breast Cancer Liquid Biopsy Market is segmented into the following categories:
By Circulating Biomarkers
-Circulating Tumor Cells
-Circulating Tumor DNA
By End User Location
- Hospital Laboratories
- Advanced Reference Laboratories
With this detailed report, Stratview Research offers one of the following free customization options to our first-time clients:
Custom Research: Stratview research offers custom research services across sectors. In the case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at email@example.com.
Opportunities & Gaps in the Asia-Pacific In Vitro Diagnostics Market - by Products & Services (Equipment, Reagents, Services, other), by Technology (Immunology, Molecular Diagnostics, POCT, Microbiology, Hematolo..
Opportunities & Gaps in the American IVD Market - by Products & Services (Equipment, Reagents, Services, other), by Technology (Immunology, Molecular Diagnostics, POCT, Microbiology, Hematology, others), by Thera..
Opportunities & Gaps in the European In Vitro Diagnostic Market - By Products & Services (Reagents & Kits, Equipment, New Technology/Connect Laboratories (AI in lab), Data Management Services, Laboratory Supp..
Opportunities and Gaps in The Global Life Sciences Reagents Segment in the Clinical Laboratories Market
Opportunities & Gaps in the Allergy Diagnostics Market: By Products (Assay Kits, Immunoassay & Elisa Analysers, Illuminometers, and Others), By Allergens (Food, Inhaled, Drug), By Type of Test (In Vivo, In Vitro)..
Opportunities & Gaps in the Laboratory Glassware Market: By Product Type (Glass Pipettes and Pipette Tips, Glass Storage Containers, Glass Flasks, Glass Beakers, Glass Petri Dishes, Glass Burettes, Other Glassware), ..
Opportunities & Gaps in the Global Laboratory Equipment Services Market: By Type of Services (Repair, Calibration, Validation, Feedback on Usage), by Service Provider Type (OEM, Distributor, and Third Party), by Type..
Opportunities & Gaps in the Global Clinical Laboratory Filtration Market: By Technology (Ultrafiltration, Microfiltration, Nano-filtration, and Reverse Osmosis), By After Sales Services (Calibration, Repair, and Vali..
Opportunities & Gaps in the Global Laboratory Information System (LIS) Market: By Type (Broad-based LIMS, Industry-specific LIMS), by Component (Services & Software), By Deployment (On Site, Remote Access and Clo..